These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8076710)

  • 1. DNA polymerase alpha as an independent prognostic parameter in non-small cell lung cancer--an immunohistochemical study.
    Tateishi M; Ishida T; Hamatake M; Fukuyama Y; Kodono S; Sugimachi K; Akazawa K
    Eur J Surg Oncol; 1994 Aug; 20(4):461-6. PubMed ID: 8076710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer.
    Carbone E; Asamura H; Takei H; Kondo H; Suzuki K; Miyaoka E; Tsuchiya R; Motta G
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):907-12. PubMed ID: 11689795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of flow cytometry in non-small-cell lung cancer.
    Rice TW; Bauer TW; Gephardt GN; Medendorp SV; McLain DA; Kirby TJ
    J Thorac Cardiovasc Surg; 1993 Aug; 106(2):210-7. PubMed ID: 8393505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.
    Hsu CP; Shen GH; Ko JL
    Lung Cancer; 2006 Jun; 52(3):349-57. PubMed ID: 16569461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification.
    Christian C; Erica S; Morandi U
    Lung Cancer; 2006 Nov; 54(2):185-91. PubMed ID: 16996167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel molecular staging protocol for non-small cell lung cancer.
    Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
    Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
    Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
    Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
    Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
    Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
    Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
    Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin expression and prognostic significance in non-small cell lung cancer.
    Donati V; Boldrini L; Dell'Omodarme M; Prati MC; Faviana P; Camacci T; Lucchi M; Mussi A; Santoro M; Basolo F; Fontanini G
    Clin Cancer Res; 2005 Sep; 11(18):6459-65. PubMed ID: 16166420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer.
    Rao J; Sayeed RA; Tomaszek S; Fischer S; Keshavjee S; Darling GE
    Ann Thorac Surg; 2007 Sep; 84(3):934-8; discussion 939. PubMed ID: 17720402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY; Liang XM; Lin SX; Luo RZ; Hou JH; Zhang L
    Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis.
    Wang J; Liu X; Jiang W; Liang L
    Chin Med J (Engl); 2000 Nov; 113(11):985-90. PubMed ID: 11776132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
    Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):87-93. PubMed ID: 15632829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of tumor size in non-small cell lung cancer larger than five centimeters in diameter.
    Cangir AK; Kutlay H; Akal M; Güngör A; Ozdemir N; Akay H
    Lung Cancer; 2004 Dec; 46(3):325-31. PubMed ID: 15541817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
    Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
    Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.